AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.12 Cr | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr |
What is the latest Contingent Liabilities ratio of AJANTA PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹8.12 Cr |
| Mar2025 | ₹8.12 Cr |
| Mar2024 | ₹4.42 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹6.76 Cr |
How is Contingent Liabilities of AJANTA PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.12 Cr | 0.00 | |
| Mar2025 | ₹8.12 Cr | 83.71 | |
| Mar2024 | ₹4.42 Cr | 9.68 | |
| Mar2023 | ₹4.03 Cr | -40.38 | |
| Mar2022 | ₹6.76 Cr | - | |
Compare Contingent Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹42,749.5 Cr | 7.3% | 17.6% | 31.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 7.3% |
17.6% |
31.9% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses